Qube Research & Technologies LTD Abb Vie Inc. Call Options Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $11.1 Million - $13.5 Million	67,500 Added 76.79%	155,400 $30.7 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $2.76 Million - $3.22 Million	17,800 Added 25.39%	87,900 $15.1 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $6.44 Million - $7.34 Million	40,300 Added 135.23%	70,100 $12.8 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $3.98 Million - $4.61 Million	29,800 New	29,800 $4.44 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $7.23 Million - $8.33 Million	50,000 New	50,000 $7.97 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.